CB Insights
Technology Market Intelligence
Technology Market Intelligence
The Column Group is a venture capital firm dedicated to creating biotechnology companies.
Phone: 415-865-2050
1700 Owens Street
Suite 500
San Francisco, 94158
California, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2021-06-10 | Synthekine | Series B | $107.5M | Canaan Partners, Deerfield Management, Emerson Collective, Janus Henderson Investors, Lilly Asia Ventures, Omega Fund Management, RA Capital Management, Rock Springs Capital, Samsara BioCapital, TCG Crossover, and Undisclosed Investors |
| 2021-05-05 | Eikon Therapeutics | Series A | $148M | Foresite Capital, Innovation Endeavors, and Lux Capital |
| 2021-03-31 | Entrada Therapeutics | Series B | $116M | 5AM Ventures, Agent Capital, CureDuchenne Ventures, Goldman Sachs, Greenspring Associates, Moore Strategic Ventures, MPM Capital, MRL Ventures, Point72 Ventures, Qatar Investment Authority, Redmile Group, Roche Venture Fund, and Wellington Management |
| 2021-03-18 | Aktis Oncology | Series A | $72M | Bristol-Myers Squibb, EcoR1 Capital, MPM Capital, Novartis, Octagon Capital, and Vida Ventures |
| 2021-03-01 | Tenaya Therapeutics | Series C | $106M | Casdin Capital, Fidelity Investments, Google Ventures, RA Capital Management, RTW Investments, and T. Rowe Price |
